GTLB vs VRTX · rev $550.4M vs P/E 30, rev $3.33B
Gitlab Inc (GTLB) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Gitlab Inc (GTLB) is a software - infrastructure company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported GTLB revenue for 2026-07-31 was $550.4M. Net income was -$41.8M. GTLB currently screens at market cap $8.39B.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
GTLB currently screens at market cap $8.39B. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the GTLB and VRTX stock pages for the full models.
Not investment advice.